Role of cysteine endopeptidases in cancerogenesis

Cancer Biotherapy and Radiopharmaceuticals

Volumn 11, Issue 3, 1996, Pages 169-176

  Siewinski, Maciej ^a   Gutowicz, Jan ^a   Zarzycki, Andrzej ^a   Mikulewicz, Wojciech ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Regional Railway Hospital of Wroclaw   (Poland)

Author keywords

cancer; cysteine endpeptidases; invasion; metastasis; neoplastic transformation

Indexed keywords

CYSTEINE; PROTEINASE; TUMOR MARKER;

ANIMAL CELL; CANCER INVASION; CARCINOGENESIS; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HOST RESISTANCE; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

EID: 0029775181     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1996.11.169     Document Type: Review

References (96)

1. Baici A, Knopfel M, Keist R. Tumor-host interactions in the rabbit V2 carcinoma stimulation of cathepsin B in host fibroblasts by a tumor-derived cytokinine. Invas Metast 1988;8:143.
2. Hiwasa T. Possible involvement of protease inhibitor ras proteins in malignant transformation. Biol Chem Hoppe Seyler 1988;369:239.
3. Sloane BF, Honn KV. Cysteine proteinases and metastasis. Cancer Metast Rev 1989;3:249.
4. Kane SE, Gottesman MM. The role of cathepsin L in malignant transformation. Semin Cancer Biol 1990;1:127.
5. Qian F, Chan SJ, Gong QM, Bajkowski AS, Steiner DF, Frankfater A. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors. Biomed Biochim Acta 1991;50:531.
6. Schmitt M, Janicke F, Graeff H. Tumor-associated proteases. Fibrynolysis 1992;6:3.
7. Duffy MJ The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 1992;10:145.
8. Jaervinen M, Rinne A, Hopsu-Havu VK. Human cystatins in normal and diseased tissue-a review. Acta Histochem 1987;82:5.
9. Lah TT, Clifford JL, Helmer KM, Day NA, Moink H, Honn KV. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim Biophys Acta 1989;993:63.
10. Rozhin J, Gomez AP, Ziegler GH. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res 1990;50:62.
11. Machleidt W, Thiele U, Assfalg-Machleidt I, Forger D, Auerswald EA. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins. Biomed Biochim Acta 1991;50:613.
12. Turk V. Cystatins as regulators of intracellular proteolysis. J Nutr Sci Vitaminol-Tokyo 1992;292.
13. Lah TT, Kokalj-Kunovar M, Strukelj B, Ringercar I, Borlic-Magnaja D, Drobnic M, Kastelic L, Babnik J, Galough R, Turk V. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int J Cancer 1992;50:36.
14. Lah TT, Kokalj-Kunovar M, Kastelic L. Cystatins and stefins in ascitic fluid from ovarian carcinoma. Cancer Lett 1992;61:243.
15. Kunimatsu K, Yamamoto K, Ichimaru E, Kato Y, Kato I. Cathepsins B, H and L activities in gingival crevicular fluid from chronic adult periodontitis patients and experimental gingivitis subjects. J Periodont Res 1990;25: 69.
16. Sohar I, Laszlo A, Gaal K, Mechler F. Cysteine an metalloproteinase activities in serum of Duchenne muscular dystrophic genotypes. Biol Chem Hoppe Seyler 1988;369: 277.
17. Nakamura Y, Takeda M, Suzuki H, Hattori H, Tada K, Hariguchi S, Hashimoto S, Nishimura T. Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease. Neurosci Lett 1991;130:195.
18. Delaisse JM, Ledent P, Vaes G. Collegenolytic cysteine proteinases bone tissue. Cathepsin B, (pro)cathepsin L and cathepsin L-like 70k Da proteinase. Biochem J 1991; 279:167.
19. Kakegawa H, Nikawa T, Tagami K, Duance VC, Etherington DJ. Participation of cathepsin L on bone resorption. FEBS-Lett 1993;321:247.
20. Maciewicz RA, Wardale RJ, Wotton SF, Duance VC, Etherington DJ. Mode of activation of the precursor to cathepsin L: Implication for matrix degradation in arthritis. Biol Chem Hoppe-Seyler 1990;371:223.
21. Trabandt A, Gay RE, Fassbender HG, Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 1991; 34:1444.
22. Leonarcie B, Gabrijelcic D, Rozman B, Drobnic-Kosorek M, Turk V. Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe Seyler 1988;369:257.
23. Assfalg-Machleidt I, Billing A, Frohlich O, Nast-Kolb D, Joka T, Jochum M, Machleidt W. The role of the kininogenes as cysteine proteinase inhibitors in local and systemic inflammation. Agents Actions Suppl 1992;38:312.
24. Varani J. Interaction of tumor cells with the extracellular matrix. Rev Biol Cellular 1987;12:1.
25. Sloane BF, Moin K, Krepela E, Rozhin J. Cathepsin B and its endogenous inhibitors: role in tumor malignancy. Cancer Metastasis Rev 1990, 9:333.
26. Sloane BF. Cathepsin B and cystatins:evidence for in cancer progression. Semin Cancer Biol 1990;1:137.
27. Siewinski M. Autologous cysteine peptidase inhibitors as potential anticancer drugs. Anti-Cancer Drugs 1993;4:97.
28. Garrett CT. Oncogenes. Critical Review Clin Chim Acta 1986;156:1.
29. Sikora K, Evan G, Watson J. Oncogenes and germ cell tumors. Int J Androl 1987;10:57.
30. Denhardt DT, Greenberg AH, Egan SE, Hamilton RT, Wright JA. Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene 1987;2:55.
31. Zhang IY, Schulz RM. Fibroblasts transformed by different ras onkogenes show dissimilar patterns of protease gene expression and regulation. Cancer Res 1992;52:6689.
32. Chambers AF, Colella R, Denhardt DT, Wilson SM. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic ras-transformed NIH 3T3 cells. Mol Carcinog 1992;5:238.
33. Hiwasa T, Sakiyama S, Noguchi S, Ha JM, Miyzawa T, Yokyama S. Degradation of cAMP-binding protein is inhibited by human c Ha-ras gene products. Biochem Biophys Res Commun 1987,731.85.
34. Hiwasa T, Sawada T, Tanaka K, Ha JM, Noguchi S, Bando Y, Kominarni E., Katunuma N. Colocalization of ras gene products and cathepsin L in cytoplasmic vesicles i v-ras-transformed NIH 3T3 mouse fibroblasts. Biomed Biochim Acta 1991;51:579.
35. Hiwasa T, Sakiyama S, Yokoyama S, Ha J.M., Noguchi S., Bando Y., Kominami E., Katunuma N. Degradation of epidermal growth factor receptors by cathepsin L-like proteinase: inhibition of the degradation by c-Ha-ras-gene products. FEBS Lett 1988;233:363.
36. Hiwasa T, Sakiyama S, Yokoyama S, Ha JM, Fujita J, Noguchi S, Bondo Y, Kominami E, Katunuma N. Inhibition of cathepsin L-induced degradation of epidermal growth factor receptors by c-Ha-ras gene products. Biochim Biophys Res Commun 1988;151:78.
37. Hiwasa T, Yokoyama S, Ha JM. c-Ha-ras gene products are potent inhibitors of cathepsin B and L. FEBS Lett 1987; 211:23.
38. Hiwasa T Internally repeated sequences in ras gene products. Biochem J 1988;254:621.
39. Hiwasa T, Fujita-Yoshigaki J, Shirozu M, Koide H, Sawada T, Sakiyama S, Yokoyama S. c Ha ras mutants with pion mutations in Gln-Val-Val- region have reduced inhibitory activity toward cathepsin B. Cancer Lett 1993;69:161.
40. Rawlings ND, Barrett AJ. Evolution of proteins of the cystein superfamily. J Mol Evol 1990;30:60.
41. Stiles CD. The biological role of oncogenes-insight from platelet derived growth factor. Cancer Res 1985;45:5215.
42. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ulrich A, Schlessinger J, Waterfield MD. Close similarity of epidermal growth factor receptor and v-erb B oncogene protein sequences. Nature 1984;307:521.
43. Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983;49:349.
44. Mullins De, Rohlich ST. The role of proteinases in cellular invasiveness. Biochim Biophys Acta 1983;695:177.
45. Sinha AA, Gleasen DF, Limas C. Localisation of cathepsin B in normal and hyperplastic human prostate by immunoperoxidase and protein A-gold techniques. Anat Res 1989;223:266.
46. Erdel M, Trcfz G, Spiess E. Localisation of cathepsin B in two human lung cancer cell lines. J Histochem 1990;38:1313.
47. Weiss RE, Liu BC, Ahlering T, Dubeau L, Droller MJ. Mechanism of human bladder tumor invasion: role of protease cathepsin B. J Urol 1990;144:798.
48. Shean K, Shuja S, Murnane MJ. Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res 1989;49:3809.
49. Chung SM. Variant cathepsin L activity from gastric cancer tissue. Jpn J Cancer Res 1990;81:813.
50. Black R, Kronheim S, Sleath P, Greenstreet T, Virca GD, March C, Kupper T. The proteolytic activation of interleukin-1 beta. Agents Actions Suppl 1991;35: 85.
51. Buttle DJ, Saklatvala J. Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation. Biochem J 1992;287:657.
52. Pagano M, Capony F, Rochefort H. Pro-cathepsin D can activate in vitro procathepsin B secreted by ovarian cancers. C R Acad Sci III 1989;309:7
53. Tsushima H, Hyadoh F, Yoshida E, Ueki A, Hopsu-Havu K. Inactive cathepsin B-like enzyme in human melanoma culture medium. Melanoma Res 1992;1:341.
54. Murnane MJ, Shean K, Ozdemirli M, Shuja S . Stage-specific increase incathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res 1991;51:1137.
55. Qian F, Frankfater A, Steiner DF Characterisation of multiple cathepsin B mRNAs in murine B16a melanoma. Anticancer Res 1991;11:1445.
56. Qian F, Bajkowski AS, Steiner DF, Chan SJ, Frankfater A Expression of five cathepsins in murine melanomas of varying [sic] metastatic potential and normal tissues. Cancer Res 1989;49, 63.
57. Laslo A, Sohar J, Karacsonyi S. Activities of serum cathepsin (B, H and L) and metalloproteinas (MMP7-ase) in patients with gastrointestinal and bronchial malignant tumours. Acta Med Hung 1990;47:107
58. Salminen A, Gottesman MM. Inhibitor studies indicate that active cathepsin L is probably essential to its own processing in cultured fibroblasts. Biochem J 1990;272:39.
59. Chauhan SS, Goldstein LJ, Gottesman MM. Expression of cathepsin L in human tumors. Cancer Res 1991;51:1478.
60. Gabrijelcic D, Svetic B, Spoic D, Skrk J, Budihna M, Dolenc I, Popovic T, Cotic V, Turk V. Cathepsin B, H and L in human carcinoma. Eur J Clin Chem Clin Biochem 1992;30:69.
61. Joseph LJ, Chang LC, Stamenkovich D, Sukhatme VP. Complete nucleotide and deduced amino acid sequences of human and muring preprocathepsin L. An abundant transcript induced by transformation of fibroblasta. J Clin Invest 1988;81:1621.
62. Hamilton RT, Bruns KA, Delago MA, Shim JK, Fang Y, Denhardt DT, Nilsen-Hamilton M. Developmental expression of cathepsin L and c Ha ras in the mouse placenta. Mol Rep Dev 1991;30:285.
63. Gasic GJ. Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metast Rev 1984;3:99.
64. Yamaguchi, Chung S. Characterisation of a cathepsin L-like enzyme secreted from human pancreatic cancer cell line HPC-YP. Cancer Res 1990;50:658.
65. Sloane BF, Rozhin J, Krepela E. The malignant phenotype and cysteine proteinases. Biomed Biochim Acta 1991;50:549.
66. Honn KV, Sloane BF. Basic mechanism and clinical treatment of tumor metastasis. Prostaglandins in tumor cell metastasis. Academic Press Inc. New York, 1985, pp 311.
67. Honn KV, Menter DG, Cavanaugh PG. A reviev of prostaglandins and the treatment of cancer. Acta Clin Belg 1983;38:53.
68. Quigley I, Cramer A, Faibrain C. Interaction of malignant cell with substrate: adhesion, degradation and migration. In Honn KV, Powers WE, Sloane BF. Mechanism of cancer metastasis. Potential therapeutic implication. Martinus Nijhoff, Boston 1985, pp 309.
69. Weiss L, Orr FW, Honn KV. Review. Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clin Expl Metastasis 1989;2:127.
70. Honn KV, Onoda JM, Menter DM. Prostacyclin in the control of tumor metastasis " In: Cohen MM ed. Biological protection with prostaglandins. Boca Raton FL: CRC Press, Boston, 1985 pp 91.
71. Menter DG, Onoda JM, Moilanen D Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation. JNCI 1987;78:961.
72. Ordinas A, Diaz-Ricard M, Almiral L, Bastida E. The role of platelets in cancer metastasis. Blood Coagul-Fibrinolysis 1990;1:707.
73. Alexander B, Pechet L, Kliman A. Proteolysis, fibrynolysis and coagulation significance in trombolytic therapy. Circulation 1962;26.596.
74. Pearlstein E, Ambogio C, Gasic GJ Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginin N-(3-ethyl-1,5,-pentadiyl) amide. Cancer Res 1989;41:4535.(1989).
75. Cavanaugh PG, Sloane BF, Bajkowski AE, Gasic GJ, Gasic TB, Honn KV. Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clin Exp Metast 1983;1:297.
76. Higashiyama M, Doi O, Kodama K, Koyama I, Ozawa Y, Hanada K. Cathepsin B expression in tumor cells and Iaminin distribution in pulmonary adenocarcinoma. J Clin Pathol 1983:46:18.
77. Lah TT, Buck MR Honn KV. The degradation of laminin by human tumor cathepsin B. Clin Expl Metast 1989;7:462.
78. Rao CN, Barsky CH, Turranova VP, Liotta L. Isolation of tumor cell laminin receptor. Biochim Biophys Res Commun 1983;111:804.
79. Tamai M, Matsumoto K, Omura S, Cortez SL, WU LT, Shah SV. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64. J Pharmacobiodyn 1986;9:672.
80. Baricos WH, O'Connor SE, Cortez SL, WU LT, Shah SV. The cysteine proteinase inhibitor E-64 reduced proteinuria in an experimental model of glomerulonephritis. Biochem Biophys Res Commun 1988;155:1318.
81. Dufek V, Jirasek V, Krai V, Matous B, Drazna E. Changes in serum cathepsin B-like activity in patients with colorectal cancer. Neoplasma 1985; 32:51.
82. Krepela E, Vicar I, Czernoch M. Cathepsin B in human breast tumor tissue and cancer cells. Neoplasma 1989;36:41.
83. Trefz G, Erdel M, Spiess E, Ebert W. Detection of cathepsin B, plasminogen activator and plasminogen activator inhibitor in human non-small lung cancer cell lines. Biol Chem Hoppe-Seyler 1990;371:617.
84. Krepela E, Kasafirek E, Novak K. Increased cathepsin B activity in human lung tumors. Neoplasma 1990;37:61.
85. Sedo A, Krepela E, Kasafirek S. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma. J Cancer Res Clin Oncol 1991;117:249.
86. Laslo A, Sohar J, Karacsonyi S. Activities of serum cathepsin (B, H and L) and metalloproteinas (MMP7-ase) in patients with gastrointestinal and bronchial malignant tumours. Acta Med Hung 1990;47:107.
87. Pietras RJ, Szego CM, Mangan CE, Seeler BJ, Burtnett MM, Orevi M. Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure. Obstet Gynecol 1978;52:980.
88. Krȩcicki T, Siewiński M. Serum cathepsin B-like activity as potential marker of laryngeal carcinoma. European Arch of Oto-Rhino-Laryngology 1992;249:293.
89. Siewiński M, Krȩcicki T, Rak J, Jarmulowicz J. Thiol proteinase inhibitors in saliva of patients with laryngological cancer. Diagn Oncol 1992;2:141.
90. Siewiński M, Krȩcicki T, Jarmulowicz J, Berdowska I, Cysteine proteinase inhibitors in serum of patients with head and neck tumors. Diagn Oncol 1992;2:323-326.
91. Siewinski M, Gutowicz J, Kielan W, Bolanowski M. Cysteine peptidase inhibitors and activators in urine of patients with colorectal cancer. Oncology 1994;51:446.
92. Berdowska I, Mikulewicz W, Siewiński M. Activity of cysteine endopeptidases, their inhibitors and activators in cancer tissues. Third International Conference on Head and Neck Cancer, San Francisco, July 26-30, 506, (1992).
93. Abrahamson M, Barrett AJ, Salvesen G, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentration in biological fluids. J Biol Chem 1987;261.11282.
94. Takeda A, Nakamura Y, Aoki Y. Enzyme-linked immunosorbent assay for the detection of cathepsinkininogen complexes in human serum J Immunol Methods 1992;147. 217.
95. Siewinski M. Method of purification of thiol proteinase inhibitors from human urine. Cancer Biochem Biophys 1991;12:33.
96. Mikulewicz W, Berdowska I, Jarmulowicz J, Siewinski M. Decrease in vivo of cysteine endopeptidases in blood of patients with tumor of larynx. Anti-Cancer Drugs 1993;4:341.